Melola Discovery

← Melola Discovery

Jurnal SINTA 1

Outcome of Patients with Metabolic-Associated Fatty Liver Disease Who Are Infected with SARS-CoV-2: A Meta-Analysis

ACTA MEDICA INDONESIANA · Vol. 57 No. 1 (2025)

ISSN
2338-2732, 0125-9326
Terbit
2025-04-15
Penerbit
The Indonesian Society of Internal Medicine
Bahasa
eng

Abstrak

Background: Metabolic-associated fatty liver disease (MAFLD) is excess fat accumulation in the liver due to metabolic syndrome. Coronavirus disease 2019 (COVID-19) is an infection caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 not only attacks the respiratory system but also involves systemic and extra-pulmonary organ disorders, including liver disorders. This review evaluates the severity of COVID-19, mortality, and length of hospital stays of patients with MAFLD who were infected with SARS-CoV-2. Methods: Literature searches were conducted through various online databases. The risk of bias assessment was conducted by two researchers using the Newcastle Ottawa Scale tool for NRSI studies, and any discrepancies were resolved by another team member. The meta-analysis was performed using Revman 5.4.1 and results were presented in forest plot by calculating the pooled odds ratio or mean difference between the MAFLD and non-MAFLD groups from the evaluated studies with a 95% CI. Results: The results of the meta-analysis using a fixed-effect model from seven studies showed that COVID-19 patients with MAFLD were associated with a higher mortality compared to those without MAFLD (OR 1.41, 95% CI 1.19-1.69, p=0.01, I2 48). However, there were no differences in COVID-19 severity (OR 3.12, IK95% 0.89–11.03, p=0.08, I2 92) and length of hospital stay (MD 1.27, CI95% 0.03–2.52, p=0.04, I2 80) between the two groups. Conclusion: MAFLD patients infected with SARS-CoV-2 were associated with higher mortality than non-MAFLD patients, but they were not associated with greater severity of COVID-19 nor a longer duration of hospitalization.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 299 tautan kepenulisan bersama · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • University of Indonesia
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Sukamto KoesnoeAfiliasi tidak diketahui9
Anshari Saifuddin HasibuanAfiliasi tidak diketahui8
Rudi PutrantoAfiliasi tidak diketahui7
Suzy MariaAfiliasi tidak diketahui6
Pringgodigdo NugrohoAfiliasi tidak diketahui6
Juferdy KurniawanAfiliasi tidak diketahui5
Evy YunihastutiAfiliasi tidak diketahui5
Iris RengganisAfiliasi tidak diketahui5
Siti SetiatiAfiliasi tidak diketahui5
Teguh Harjono KarjadiAfiliasi tidak diketahui5
Hamzah ShatriAfiliasi tidak diketahui5
Ikhwan RinaldiAfiliasi tidak diketahui5
Irsan HasanAfiliasi tidak diketahui4
Imam SubektiAfiliasi tidak diketahui4
Samsuridjal DjauziAfiliasi tidak diketahui4
Pradana SoewondoAfiliasi tidak diketahui3
Rino Alvani GaniAfiliasi tidak diketahui3
Cosmas Rinaldi A LesmanaAfiliasi tidak diketahui3
Kemal Fariz KalistaAfiliasi tidak diketahui3
Murdani AbdullahAfiliasi tidak diketahui3
Wismandari WisnuAfiliasi tidak diketahui3
Sally Aman NasutionAfiliasi tidak diketahui3
Robert SintoAfiliasi tidak diketahui3
Cleopas Martin RumendeAfiliasi tidak diketahui3
Tri Juli Edi TariganUniversity of Indonesia2
Suharko SoebardiAfiliasi tidak diketahui2
Dante Saksono HarbuwonoAfiliasi tidak diketahui2
Budiman DarmowidjojoAfiliasi tidak diketahui2
Dicky Levenus TahaparyAfiliasi tidak diketahui2
Farid KurniawanAfiliasi tidak diketahui2
Indrati SuroyoAfiliasi tidak diketahui2
Alvita Dewi SiswoyoAfiliasi tidak diketahui2
Soehartati GondhowiardjoAfiliasi tidak diketahui2
Arif MansjoerAfiliasi tidak diketahui2
Andri SanityosoAfiliasi tidak diketahui2
Marcellus SimadibrataAfiliasi tidak diketahui2

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://www.actamedindones.org/index.php/ijim/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 8 Nov 2026.
Metadata asli (oai_dc) 
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Outcome of Patients with Metabolic-Associated Fatty Liver Disease Who Are Infected with SARS-CoV-2:  A Meta-Analysis</dc:title>
	<dc:creator>Jasirwan, Chyntia Olivia Maurine</dc:creator>
	<dc:creator>Purnamasari, Dyah</dc:creator>
	<dc:creator>Widhani, Alvina</dc:creator>
	<dc:creator>Kamila, Tasya</dc:creator>
	<dc:subject xml:lang="en-US">COVID-19</dc:subject>
	<dc:subject xml:lang="en-US">MAFLD</dc:subject>
	<dc:subject xml:lang="en-US">outcome</dc:subject>
	<dc:subject xml:lang="en-US">severity</dc:subject>
	<dc:subject xml:lang="en-US">mortality</dc:subject>
	<dc:subject xml:lang="en-US">length of hospital stays</dc:subject>
	<dc:description xml:lang="en-US">Background: Metabolic-associated fatty liver disease (MAFLD) is excess fat accumulation in the liver due to metabolic syndrome. Coronavirus disease 2019 (COVID-19) is an infection caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 not only attacks the respiratory system but also involves systemic and extra-pulmonary organ disorders, including liver disorders. This review evaluates the severity of COVID-19, mortality, and length of hospital stays of patients with MAFLD who were infected with SARS-CoV-2. Methods: Literature searches were conducted through various online databases. The risk of bias assessment was conducted by two researchers using the Newcastle Ottawa Scale tool for NRSI studies, and any discrepancies were resolved by another team member. The meta-analysis was performed using Revman 5.4.1 and results were presented in forest plot by calculating the pooled odds ratio or mean difference between the MAFLD and non-MAFLD groups from the evaluated studies with a 95% CI. Results: The results of the meta-analysis using a fixed-effect model from seven studies showed that COVID-19 patients with MAFLD were associated with a higher mortality compared to those without MAFLD (OR 1.41, 95% CI 1.19-1.69, p=0.01, I2 48). However, there were no differences in COVID-19 severity (OR 3.12, IK95% 0.89–11.03, p=0.08, I2 92) and length of hospital stay (MD 1.27, CI95% 0.03–2.52, p=0.04, I2 80) between the two groups. Conclusion: MAFLD patients infected with SARS-CoV-2 were associated with higher mortality than non-MAFLD patients, but they were not associated with greater severity of COVID-19 nor a longer duration of hospitalization.</dc:description>
	<dc:publisher xml:lang="en-US">The Indonesian Society of Internal Medicine</dc:publisher>
	<dc:date>2025-04-15</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>http://www.actamedindones.org/index.php/ijim/article/view/2931</dc:identifier>
	<dc:source xml:lang="en-US">Acta Medica Indonesiana; Vol. 57 No. 1 (2025): Acta Medica Indonesiana; 61</dc:source>
	<dc:source>2338-2732</dc:source>
	<dc:source>0125-9326</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>http://www.actamedindones.org/index.php/ijim/article/view/2931/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2025 Acta Medica Indonesiana</dc:rights>
</oai_dc:dc>